Recent Advances in Perioperative Immunotherapies in Lung Cancer
Several clinical trials have been revolutionizing the perioperative treatment of early-stage non-small cell lung cancer (NSCLC). Many of these clinical trials involve cancer immunotherapies with antibody drugs that block the inhibitory immune checkpoints programmed death 1 (PD-1) and its ligand PD-L...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2023-09-01
|
| Schriftenreihe: | Biomolecules |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2218-273X/13/9/1377 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|